SELLAS Life Sciences (SLS) Current Deferred Revenue (2020 - 2021)
Historic Current Deferred Revenue for SELLAS Life Sciences (SLS) over the last 3 years, with Q1 2021 value amounting to $900000.0.
- SELLAS Life Sciences' Current Deferred Revenue changed N/A to $900000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $900000.0, marking a year-over-year change of. This contributed to the annual value of $5.6 million for FY2020, which is N/A changed from last year.
- According to the latest figures from Q1 2021, SELLAS Life Sciences' Current Deferred Revenue is $900000.0.
- SELLAS Life Sciences' Current Deferred Revenue's 5-year high stood at $5.6 million during Q4 2020, with a 5-year trough of $900000.0 in Q1 2021.